Alkyl-Aryl-Vancomycins: Multimodal Glycopeptides with Weak Dependence on the Bacterial Metabolic State

Paramita Sarkar1, Debajyoti Basak1, Riya Mukherjee1

  • 1Antimicrobial Research Laboratory, New Chemistry Unit and School of Advanced Materials, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru 560064, Karnataka, India.

Insights

New alkyl-aryl-vancomycins (AAVs) show potent activity against resistant bacteria. The lead compound AAV-qC10 eradicates biofilms and persister cells, offering a promising new therapeutic strategy for drug-resistant infections.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Growing resistance to last-resort antibiotics like vancomycin is a major public health threat.
  • Bacterial biofilms and persister cells pose significant challenges to conventional antibiotic therapies.
  • Novel therapeutic agents are urgently needed to combat multidrug-resistant Gram-positive bacterial infections.

Purpose of the Study:

  • To develop and characterize novel vancomycin derivatives with enhanced activity against resistant bacteria.
  • To investigate the mechanism of action of these new compounds, focusing on their effects on bacterial metabolism, cell membranes, and growth.

Main Methods:

  • Synthesis and characterization of alkyl-aryl-vancomycins (AAVs).
  • In vitro testing of AAV potency against vancomycin-resistant enterococci and staphylococci, including methicillin-resistant Staphylococcus aureus (MRSA).
  • Assessment of AAV-qC10's bactericidal activity, metabolic dependence, biofilm disruption, membrane effects, and impact on the MinD protein.
  • In vivo efficacy evaluation of AAV-qC10 in a murine thigh infection model.

Main Results:

  • AAVs demonstrated high potency against vancomycin-resistant enterococci and staphylococci.
  • The lead compound, AAV-qC10, exhibited bactericidal activity, was weakly dependent on bacterial metabolism, and eradicated non-growing MRSA cells.
  • AAV-qC10 disrupted MRSA biofilms and exhibited dual action by inhibiting cell wall biosynthesis and disrupting the bacterial membrane.
  • AAV-qC10 delocalized the MinD protein, impairing bacterial growth through multiple mechanisms.
  • AAV-qC10 showed superior efficacy against MRSA in a murine thigh infection model compared to vancomycin.

Conclusions:

  • Alkyl-aryl-vancomycins represent a promising new class of antibiotics effective against drug-resistant Gram-positive bacteria.
  • AAV-qC10's multifaceted mechanism of action, including targeting biofilms and persister cells, offers a significant advantage over vancomycin.
  • These findings support further development of AAVs for combating challenging bacterial infections and overcoming antibiotic resistance.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.3K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
662
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
11.1K
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.8K
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
281
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
172